The Cancer Research UK & UCL Cancer Trials Centre (CTC) work with clinical and non-clinical investigators from across the UK to design and conduct national and international clinical trials and research projects to the highest quality and standards. The aim of our work is to improve patient care and clinical practice, and find out more about how cancer grows and becomes resistant to therapies in order to develop more effective treatments. The CTC is a UK Clinical Research Collaboration (UKCRC) registered Clinical Trials Unit. Using a breadth of study designs (observational, and phase I to III clinical trials) CTC studies cover the following key areas:
View our trials portfolio spread across ten main cancer groups.
Book your place on one of our specialist training courses or find out more about UCL postgraduate degrees.
Find out more about working with the CTC on a trial or a research project.
Advice and guidance for patients who are trying to find out more about clinical trials.
What to do if you would like to make a donation to the Cancer Trials Centre
'Immunotherapy for solid tumours - 29th June 2022'
29/06/2022
'Immunotherapy for Haematological Cancers - 29th June 2022'
'Trial outcomes - what are we trying to measure? - 7th July 2022'
07/07/2022
CTC studies to be exhibited at London’s Science Museum
An exhibition featuring the CTC-coordinated studies TRACERx and PEACE opens at the Science Museum in London today. Titled ‘Cancer Revolution [...]
PeRSEVERE project looks at withdrawal of consent in clinical studies
PRincipleS for handling end-of-participation EVEnts in clinical trials REsearch (PeRSEVERE) The UKCRC Registered CTU Network’s PeRSEVERE pro [...]
Clinical study to investigate new personalised treatment for ovarian cancer
Dr Michelle Lockley from Barts Cancer Institute at Queen Mary University of London has received funding from Barts Charity (approximately £5 [...]
Analysis published for CTC brain cancer study
The findings of a CTC-coordinated brain cancer study have been published in the oncology journal Cancers. The GALA-5 team have provided the [...]
Copyright © 2022 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us